Luis Russo

Luis Russo

About

Detail

CEO
Rio de Janeiro, State of Rio de Janeiro, Brazil

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • Care Access
    CEO
    Care Access
    Jul 2022 - Current (4 years 3 months)
    CEO da empresa CAREACCESS Brasil especializada em DCT - Decentralized Clinical Trials.
  • Selfemployed
    Consultancy & Advice in Clinical Trial Center Set up
    Selfemployed
    Jan 2021 - Current (5 years 9 months)
  • IBPClin  Instituto Brasil de Pesquisa Clínica  Clinical Trial Center
    Director of Clinical Tral Center
    IBPClin Instituto Brasil de Pesquisa Clínica Clinical Trial Center
    Jan 2021 - Current (5 years 9 months)
  • IBPClin  Instituto Brasil de Pesquisa Clínica  Clinical Trial Center
    Principal Investigator Covid Vaccine Trials
    IBPClin Instituto Brasil de Pesquisa Clínica Clinical Trial Center
    Jun 2020 - Current (6 years 4 months)
  • IBPClin  Instituto Brasil de Pesquisa Clínica  Clinical Trial Center
    CEO - Diretor - Médico Investigador (Director and Principal Investigator) e Consultor em Pesquisa
    IBPClin Instituto Brasil de Pesquisa Clínica Clinical Trial Center
    May 2019 - Aug 2022 (3 years 4 months)
  • C
    CEO-Medical Director
    CCBR Brasil Center for Clinic Research
    May 2003 - Aug 2022 (19 years 4 months)
  • C
    CEO-Medical Director
    CCBR BRASIL CENTRO DE ANALISES E PESQUISAS CLINICAS LTDA
    May 2003 - Aug 2022 (19 years 4 months)
  • C
    CEO of CCBR BRAZIL MD, PhD, MBA, BCMAS.
    CCBR Brazil
    May 2003 - Jun 2020 (17 years 2 months)
    Founder and CEO the CCBR BRAZIL Clinical Research Center, dedicated to conduct study for the development of new drugs (multicentric studies to national and multinational industrys).

    Clinical Research Projects- Princiapal Investigator or Co-investigator in Multicentric Studies for Novartis, Pfizer, Roche, Eli Lilly, Boeringer, Sanofi-Aventis, Takeda, Mannkind, Nordic,
    IQVIA, PPD, ACHÉ, EURFARMA, CRISTALIA and others international and Brazilians biotechs;.
    Total more than 120 multicentric clinical trials.
  • C
    Assistant Professor in Endocrinology and Diabetes, Catholic University of Rio de Janeiro-PUC-IEDE
    Catholic University of Rio de Janeiro
    Mar 2003 - May 2009 (6 years 3 months)
    Assistant Professor in Endocrinology and Diabetes
  • F
    Densso Clinic
    Founder and Director
    Jan 1991 - Aug 2022 (31 years 8 months)
    Founder of the Densso Clinic especialized in Diagnostics and Research of Osteoporosis, pioneer of the bone densitometry method in the country, imported first dexa equipament, from U.S. to the city of Rio de Janeiro.
  • N
    Medical Resident
    Navy Brasilian Hospital Marcílio Dias
    Jan 1983 - Feb 1985 (2 years 2 months)
Education verified_user 0% verified
  • F
    PhD, in Public Health of Children and Woman
    FIO CRUZIFFRJ BRAZIL
    Jan 2009 - Jan 2010 (1 year 1 month)
  • FGV  Fundação Getulio Vargas
    Master of Business Administration (MBA, Management in Children and Women Health
    FGV Fundação Getulio Vargas
    Jan 2000 - Jan 2004 (4 years 1 month)
  • Universidade Federal do Rio de Janeiro
    MD, Medicine
    Universidade Federal do Rio de Janeiro
    Jan 1977 - Jan 1982 (5 years 1 month)
  • C
    Master in Science and Pos-Graduation 1987-1991
    Catholic University of Rio de Janeiro PUCIEDE
  • ACMA
    BCMAS, Pesquisa Clínica
    ACMA
Awards verified_user 0% verified
  • A
    Founder and member of the BRAZIL ALLIANCE FOR CLINICAL RESEARCH
    ALIANÇA PESQUISA CLÍNICA BRASIL
    This is an unique and important initiative to increase Brazil participation in the competitive world scenario of Clinical Research. Research sites, Investigators, chronic diseases associations leaders, universities, congress members, and CROs directors are working together to improve country capabilities, to improve volunteer protection and participation in the most recent new advances in medical science and speed up regulatory submissions and approvals in the country.
  • A
    Former Member of the National Academy of Pharmaceutical Medicine
    ACADEMIA NACIONAL DE MEDICINA FARMACEUTICA
Publications verified_user 0% verified
  • O
    The Effect of Teriparatide Compared With Risedronate on Reduction of Back Pain in Postmenopausal Women With Osteoporotic
    Osteoporosis International Jan
    co-author
  • I
    Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Gener
    International Osteoporosis Foundation and National Osteoporosis Foundation Apr
    co- author
  • S
    Endocrinology of Aging
    Servier Book Apr
    co author
  • T
    Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis
    The New England Journal of Medicine Nov
    co author
  • C
    Impact of Clinical Study regulatory Approval Delays in Brazil
    Clinical Researcher Dec
    Impact of Clinical Studies Regulatory Approval Delays in Brazil
    Gustavo Luiz Ferreira Kesselring, MD; Vitor Harada, PharmD, MBA; Freddy Goldberg Eliaschewitz, MD; Raffaella Picciotti, PharmD, MBA; Paula Goulart Pinheiro Machado, PhD, MD, MBA; Luis Augusto Tavares Russo, MD

    This paper analyzes Brazilian participation in international clinical trials, as well as the impact of the regulatory process on studies in the country. The Brazilian regulatory process takes, on average, one year, and patient recruitment lags behind such efforts in other countries. Regulatory timelines actually increased following the launch of a new electronic submission tool, which highlights the need to simplify the steps and root out the duplicated
  • B
    Body Composition, Metabolic Syndrome and Insulin Resistance in Type 1 Diabetes Mellitus
    Brazilian Archives of Endocrinology and Metabolism Sep
    co-author
  • E
    Osteoporosis: 100 Answers for Your Questions
    EdRecordBook Mar
    co-author
  • S
    Profile of Clinical Research Subjects in an Independent Outpatient Center
    Science and Health Mar
    co-author
  • A
    Concentration of 25-hydroxyvitamin D in postmenopausal womwn with low bone mineral density
    Arq Bras Endocrinol Metab Jan
    co-author
  • A
    Ensuring Post-Acess Drug in Clinical Studies
    ABRACO Brazilian Association of Clinical Research Organizations Representative Feb
    co author
This is a community-created genome.